Compare Bio Protocol (BIO) vs Sign (SIGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Sign — how do they compare? Bio Protocol trades at Rp439.65 (market cap Rp1T, Rp164,15M 24h volume), while Sign trades at Rp113.5 (market cap Rp271,01M, Rp66,53M 24h volume). The key difference: Bio Protocol is far larger — about 3689.9× Sign's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 2,4B / 10B SIGN (24%) for Sign. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Sign for 21 Days on average.
| BIO | SIGN | |
|---|---|---|
Market Cap | Rp1T | Rp271,01M |
Volume (24h) | Rp164,15M | Rp66,53M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,4B / 10B SIGN (24%) |
Typical Hold Time | 18 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
SIGN token currently trades at Rp115.74 with a market cap of Rp275.68M, showing bearish technical signals with 18 sell indicators versus 3 buy signals. The token faces resistance at Rp117-Rp120 while finding support at Rp112-Rp115 levels. With only 24% of the maximum 10M supply in circulation and average hold time of 21 days, the asset shows limited distribution but stable holding patterns among current investors.
Overall outlook remains cautious due to strong bearish technical momentum despite neutral oscillators. Key opportunity lies in potential rebound from oversold RSI levels, while major risks include low liquidity and limited market depth. Investors should monitor breakout above Rp120 resistance for trend reversal confirmation.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Sign
Sign is developing global infrastructure for credential verification and token distribution through two main products. The Sign Protocol is an omni-chain attestation protocol that supports digital public infrastructure for governments and serves as a foundational layer for decentralized applications. TokenTable is a smart contract-based platform that streamlines token distribution processes such as airdrops, vesting, and unlocks, allowing for seamless and transparent on-chain management.
Read more on SIGN →
